THE PROMISE AND PERILS OF GEROSCIENCE
~ Sanvi Mohanty
After immense development in the field of disease treatment and medicine, humanity is now eager to explore the possibility of delaying death, if not conquering it. Researchers are delving into various methods like gene therapy, stem cell treatments, epigenetic reprogramming, regenerative medicine etc. to delay aging, extend health-span, and potentially increase human life expectancy.
However, just like any other scientific field where progress has been attempted and fulfilled, this area is also not without challenges.
The Complexity of Aging
Aging is a complex process involving multiple interconnected biological processes. It is influenced by a lot of intrinsic factors like genetics as well as extrinsic factors like diet, nutrition and lifestyle. Developing therapies, drugs and serums that can navigate through such complexities and deliver expected results is quite challenging.
Translating Animal Studies to Humans
Many anti-aging technologies have shown remarkable results when tested on such lab animals. However, human biology is very much different and complex and hence, treatments that may have worked in lab testing may not produce the same outcomes in people.
High Costs and Accessibility
Research and development require high capital and cutting-edge technology which is often difficult to access. Ensuring affordability and equitable access remains a significant obstacle.
Regulatory Barriers
Aging is not classified as a disease in most countries because of which obtaining approval for anti-aging therapies is difficult. Regulatory agencies evaluate treatments for health conditions caused by aging, but rarely for aging as a whole.
_edited.png)
As interesting and challenging the field of longevity science is, it also comes with some long-term concerns. Anti-aging technologies may carry biological risks, including unintended genetic changes, immune reactions, and increased cancer risk, with long-term effects still uncertain. Increased life expectancy could also contribute to overpopulation and place additional strain on resources. Furthermore, the growing anti-aging industry has attracted companies promoting unproven therapies and supplements. Inadequate regulation and limited scientific evidence may expose consumers to ineffective or unsafe products. These concerns highlight the need for careful research and stronger oversight.
_edited.png)
Multiple ethical concerns are also raised about whether this technology will be accessible to all or will it contribute towards increasing the disparity between the upper and lower class. Limited access to life-extending technologies could widen social inequalities if only wealthy individuals benefit. People also question whether aging should be treated as a disease or as a natural part of the life cycle. Other concerns revolve around population sustainability and human identity. Longer lifespans can pose as a challenge to sustainability and may transform human identity, relationships, and the meaning of life.
Extended life span and increase in life expectancy creates a risk of overpopulation and can potentially lead to intense competition for resources and unequal distribution of it. It impacts various social and personal institutions like family structure and career path as well as government policies involving pension and healthcare. Hence, careful planning and responsible innovation will be essential to ensure that the benefits of longevity are distributed sustainably and fairly.
_edited.png)
